Bridging the donor gap: a prospective comparative study of obstetric and perinatal outcomes based on gamete sources in IVF at a tertiary care centre of South India
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20263034Keywords:
Donor gametes, IVF, Dual donor, , Pre-eclampsia, Hypertensive disorders of pregnancy, ART regulation actAbstract
Background: The assisted reproductive technology (regulation) act of 2021 has standardized third-party gamete donation in India. However, the introduction of non-maternal genetic material creates an allogenic state that potentially compromises placentation and increases obstetric risks. This study evaluated maternal and perinatal outcomes across different gamete configurations in a South Indian tertiary care facility.
Methods: This prospective comparative observational study consecutively enrolled 125 IVF-conceived pregnancies over an 18-month period. The cohort was stratified into: autologous (n=98), donor sperm (n=11), donor egg (n=8), and dual donor (n=8). Relative risks (RR) and 95% confidence intervals (CI) were calculated. Multivariable logistic regression adjusted for maternal age and pre-existing comorbidities to identify independent predictors of adverse outcomes.
Results: In crude analysis, the dual donor cohort carried the highest risk for hypertensive disorders of pregnancy (HDP) (100% incidence; RR: 1.707) and severe pre-eclampsia (75% incidence; RR: 4.641). On multivariable regression, dual donor status emerged as the only significant independent predictor for HDP, showing a 12-fold increase in disease odds (OR: 12.06, 95% CI: 0.68–214.80, p=0.040). Isolated donor sperm or oocyte configurations did not show independent risk predictions for HDP or preterm delivery (p>0.05). Caesarean section rates were exceptionally high across all donor arms (81.8% to 100%). Perinatal outcomes, including neonatal intensive care admissions and congenital anomalies, were reassuringly similar across cohorts, although extremely low birth weight was selectively elevated across all donor categories.
Conclusions: Dual donor gamete use is an independent predictor of hypertensive disorders of pregnancy. The elevated clinical risks warrant early high-risk triaging, timely tertiary referral, and proactive first-trimester prophylactic strategies.
References
Romero R, Kalache KD, Kada N. Timing the delivery of the preterm severely growth restricted fetus: venous Doppler, cardiotocography on the biophysical profile. Ultrasound Obstet Gynacol. 2002;19:118-21.
Giles WB, Trudringer BJ, Baird PJ. Fetal Umbilical flow velocity wave form and placental resistance pathological co-relation. Br J Obstet Gynacol. 1985;92:31-8.
Mendez MA, Gayta MV, Flores R. Doppler ultrasound evaluation in preeclampsia. BMC Res Notes. 2013;19:477.
Gramellini D, Folli MC, Raboni S, Vadora E, Merialdi A. Cerebral-umbilical Doppler ratio as a predictor of adverse perinatal outcome. Obstet Gynecol. 1992;79(3):416-20.
Bano S, Chaudhary V, Pande S, Mehta VC, Sharma AK. Colour Doppler evaluation of cerebral umbilical pubatility ratio and its usefulness in the diagnosis of intrauterine growth restriction and prediction of adverse perinatal outcome. Indian J Radiol Imaging. 2010;20(1):20-5.
Mari G, Hanif F, Kruger M, Cosmi E, Forgas SJ, Treadwell MC. Middle cerebral artery peak systolic velocity a new Doppler parameter in the assessment of growth restricted fetus. Ultrasound Obstet Gynacol. 2007;29(3):310-6.
Schenone MH, Mari G. The MCA Doppler and its role in the evaluation of fetal anemia and fetal growth restriction. Clin Perinatal. 2011;38(1):83-102.
Hecher K, Campbell S, Doyle P, Harrington K, Nicoladies K. Asessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Circulation. 1995;91:129-38.
Baschat AA, Gembruch U, Weiner CP, Harman CR. Qualitative venous Doppler waveforms analysis improves prediction of critical perinatal outcome in premature growth restricted foetuses. Ultrasound Obstet Gynacol. 2003;22:240-5.
Brown MA, Lindheimer MD, Swiet M, Assche VA, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:19-24.
Kurmanavicius J, Florio I, Wisser J, Hebisch G, Zimmermann R, Muller R et al. Refence resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24-42 weeks of gestation. Ultrasound Obstet Gynecol. 1997;10:112-20.
Ozeren M, Dinc H, Ekmen U, Senekayli C, Aydemir V. Umbilical and middle cerebral artery Doppler indices in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol. 1999;82:11-6.
Yoon BH, Lee CM, Kim SW. An abnormal umbilical artery waveform: A strong and independent predictor of adverse perinatal outcome in patients with preeclampsia. Am J Obs Gyn. 1994;171:713-21.